REGISTERED
on 09 May 2023
Last Applicant/ Owned by
680 Folsom Street, 5th Floor
San Francisco
CA
94107
Serial Number
97346972 filed on 05th Apr 2022
Registration Number
7048729 registered on 09th May 2023
Correspondent Address
Jordan A. LaVine
Filing Basis
1. use application currently
Disclaimer
NO DATA
A KOMODO HEALTH COMPANY
Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demograph Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Platform-as-a-service (PaaS) featuring computer software platforms that deliver market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries; Business technology software consultation services in the health care and life science industries; Software development and product development consulting in the field of the health care and life science industries; Cloud computing featuring software for processing data, creating market simulations for commercialization of products in the fields of biotechnology, rare diseases, and specialty pharmaceuticals; Consultancy in the field of software design; Consulting services in the field of software as a service (SAAS); Software design and development; Computer software consultation; Computer software consulting; Computer software design for others; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others; Design, development and implementation of software; Design, development, and implementation of software for emerging biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization
First Use Date in General
31st Dec 2020
First Use Date in Commerce
31st Dec 2020
Class [035]
Advertising, Business & Retail Services
Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Providing business information in the field of the healthcare and life sciences industries; Business consulting services to businesses in the healthcare and life sciences industries
First Use Date in General
31st Dec 2020
First Use Date in Commerce
31st Dec 2020
Mark Details
Serial Number
No 97346972
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th May 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th May 2023 | REGISTERED-PRINCIPAL REGISTER |
| 21st Feb 2023 | PUBLISHED FOR OPPOSITION |
| 21st Feb 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 01st Feb 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Jan 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Jan 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 04th Jan 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 04th Jan 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 27th Dec 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |